REG - Oxford Instruments - Trading Update

Oxford InstrumentsAnnouncement

13/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220413:nRSM1755Ia&default-theme=true

RNS Number : 1755I  Oxford Instruments PLC  13 April 2022

Oxford Instruments plc

Full Year Trading Update - 13 April 2022

 

Oxford Instruments plc, a leading provider of high technology products and
services to industrial companies and scientific research communities, is today
issuing a trading update for the year ending 31 March 2022.

 

We expect revenue and adjusted operating profit for the full year ending 31
March 2022 to be marginally ahead of our expectations, despite supply chain
disruption and cost inflation. The Group is expected to deliver further
improvement in operating margin, as our Horizon strategy drives growth in
attractive end markets, improved operational efficiency and the transformation
of our service offering.

 

This full year performance reflects good progress in the second half of the
financial year, with continued strong order growth, supported by resilient
end-markets, leaving the Group with a healthy order book as it enters the
current financial year.

 

Oxford Instruments' results for the full year ending 31 March 2022 will be
released on 14 June 2022.

 

 

Notes:

 

1. adjusted operating profit is before amortisation and impairment of acquired
intangible assets, acquisition items, and the mark-to-market revaluation of
financial derivatives

 

 

Enquiries:

 

Oxford Instruments plc
 
            Tel:  01865 393200

Ian Barkshire, Group Chief Executive

Gavin Hill, Chief Financial Officer

 

MHP
Communications
Tel:  020 3128 8990

Katie Hunt/Peter Lambie/Charlie Protheroe

oxfordinstruments@mhpc.com (mailto:oxfordinstruments@mhpc.com)

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors

 

About Oxford Instruments plc

 

Oxford Instruments designs, supplies and supports high-technology tools and
systems with a focus on research and industrial applications. Innovation has
been the driving force behind Oxford Instruments' growth and success for 60
years, supporting its core purpose to address some of the world's most
pressing challenges.

 

The first technology business to be spun out from Oxford University, Oxford
Instruments is now a global company and is listed on the FTSE250 index of the
London Stock Exchange (OXIG).  Its strategy focuses on being a
customer-centric, market-focused Group, understanding the technical and
commercial challenges faced by its customers. Key market segments include
Semiconductor & Communications, Advanced Materials, Healthcare & Life
Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low
temperature and high magnetic field environments; Nuclear Magnetic Resonance;
X-ray, electron, laser and optical based metrology; atomic force microscopy;
optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased
connectivity, improved health and leaps in scientific understanding. Their
advanced products and services allow the world's leading industrial companies
and scientific research communities to image, analyse and manipulate materials
down to the atomic and molecular level, helping to accelerate R&D,
increase manufacturing productivity and make ground-breaking discoveries.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTBKBBKABKDPQD